In dendritic cells, RT induces YTHDF1, which enhances cathepsin translation and accelerates lysosomal degradation of activated STING complexes; DC-specific Ythdf1 loss boosts IFN-I, cross-priming, and tumor control after RT or radio-immunotherapy. The gene discussed is STING1; the disease is neoplasm.